Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy

@article{Bellentani2000PrevalenceOA,
  title={Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy},
  author={Stefano Bellentani and Gioconda Saccoccio and Flora Masutti and Lory Croc and Giovanni Brandi and Franco Sasso and Giovanni Cristanini and Claudio Tiribelli},
  journal={Annals of Internal Medicine},
  year={2000},
  volume={132},
  pages={112-117}
}
Unexplained abnormalities on liver function tests are common and often perplexing. Fatty liver, or hepatic steatosis, is a common clinical and histologic finding. When hepatic steatosis does not coexist with alcoholic hepatitis or steatohepatitis, it is a benign condition (1, 2). Fatty liver is usually attributed to alcohol abuse. Although the hepatotoxicity of ethanol has been well established, only 8% to 20% of persons with chronic alcoholism develop cirrhosis (3). In the Dionysos Study, a… Expand

Paper Mentions

Interventional Clinical Trial
A recent review demonstrated that Non-alcoholic fatty liver disease (NAFLD) affects 10-35% of the adult population worldwide, with the prevalence approaching 85-100% in obese… Expand
ConditionsNAFLD, NASH - Nonalcoholic Steatohepatitis, Obesity, (+1 more)
InterventionDietary Supplement
Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis
Metabolic steatosis or non-alcoholic fatty liver (NAFLD) is the most common cause of chronic liver injury in Western countries. Histological signs of necroinfl ammation, indicating the presence ofExpand
Nonalcoholic fatty liver disease.
TLDR
A review of the clinical literature and selected basic information about NAFLD challenges some of the assumptions about the clinical importance of the disease. Expand
Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
TLDR
The clinical impact of NAFLD has been demonstrated in large cohort studies by the overprevalence of cirrhosis and hepatocellular carcinoma in obese and diabetic patients. Expand
Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) embraces a wide range of metabolic hepatic injuries that are characterized by steatosis, and it currently represents the most common liver disease in WesternExpand
Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations.
TLDR
Investigation of liver histology and serum liver enzymes remains the only proven method to distinguish between simple steatosis and NASH, a condition far more likely to progress to cirrhosis. Expand
Review article: non‐alcoholic fatty liver disease and hepatitis C – risk factors and clinical implications
  • A. Sanyal
  • Medicine
  • Alimentary pharmacology & therapeutics
  • 2005
TLDR
The presence ofNAFLD in subjects with hepatitis C genotype 1 infection is most strongly associated with the presence of the metabolic syndrome and insulin resistance, and the value of treating insulin resistance and NAFLD prior to antiviral therapy remains to be experimentally verified. Expand
Clinical update on non-alcoholic fatty liver disease and steatohepatitis.
TLDR
NAFLD prevalence in the general population ranges from 16 to 25% in adults 4 and from 10 to 19% in children and varies with ethnicity, with the highest prevalence among the Hispanic population and the lowest among the AfroAmerican one. Expand
Nonalcoholic Fatty Liver Disease (NAFLD) - A Disease of New Era
TLDR
Therapeutic strategies aimed at modulating insulin resistance, managing risk factors, including reduction of weight normalizing lipoprotein metabolism, and down regulating inflammatory mediators with probiotics have promising potential. Expand
Metabolic disturbances in non-alcoholic fatty liver disease.
TLDR
The epidemiology of NAFLD is discussed to describe the magnitude of the future potential public health problem; extra- and intra-hepatic mechanisms contributing to the pathogenesis ofNAFLD are discussed, a better understanding of which may help in the development of novel treatments for this condition. Expand
Non-alcoholic fatty liver: a common manifestation of a metabolic disorder.
TLDR
Non-alcoholic fatty liver is now thought to be the commonest cause of abnormal liver enzymes encountered in general practice, and to result in cirrhosis in a significant proportion of the patients. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 36 REFERENCES
Excess weight risk factor for alcoholic liver disease
TLDR
The results show that the presence of excess weight for at least 10 years is a risk factor for cirrhosis, AAH, and steatosis in patients with alcoholic liver disease. Expand
Drinking habits as cofactors of risk for alcohol induced liver damage
TLDR
The data show that in an open population the risk threshold for developing cirrhosis and NCLD is 30 g ethanol/day, and this risk increases with increasing daily intake, and drinking multiple different alcoholic beverages both increase the risk of developing alcohol induced liver damage. Expand
Liver in obesity.
TLDR
There was no evidence that obesity per se could result in severe liver damage, and there was a highly significant correlation between the daily ethanol intake and the degree of overweight. Expand
The natural history of nonalcoholic fatty liver: A follow‐up study
TLDR
In the absence of preexisting fibrosis or steatohepatitis, fatty liver of nonalcohol‐induced origin is an extremely benign condition. Expand
Non-alcoholic steatohepatitis. Report of five cases and review of the literature.
We describe three men and two women, aged 18-50, with an occasional finding of increased aspartate and alanine aminotransferase and gamma-glutamyl transpeptidase levels in the absence of any drugExpand
Prevalence of chronic liver disease in the general population of northern Italy: The dionysos study
TLDR
In those subjects with alcohol abuse, viral infection, especially hepatitis C virus, played an important role in the deterioration of chronic liver disease and its progression to hepatocellular carcinoma. Expand
Prevalence of fatty liver in a general population of Okinawa, Japan.
TLDR
Prevalence of fatty liver increased with age to a maximum in persons 40-49 years of age and overall was 14.0%, and obesity was the strongest associated factor in both sexes and in males alcohol was also a strong factor. Expand
Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people.
TLDR
The results suggest the possibility that hypertension in alcohol consumers, and also in obese people, relates at least partly to hyperinsulinaemia associated with progression in hepatic steatosis. Expand
Subclinical Addison's disease: a cause of persistent abnormalities in transaminase values.
TLDR
Hepatologists should consider subclinical Addison's disease as a cause of persistently increased transaminase levels with constitutional symptoms in the absence of evidence for fatty liver as well as viral and autoimmune markers. Expand
Fatty liver hepatitis and cirrhosis in obese patients.
TLDR
The pathologic picture resembled that of alcohol and postjejunoileal bypass-induced liver diseases suggesting a common denominator in these three conditions. Expand
...
1
2
3
4
...